Police get epinephrine kits to treat allergic emergencies—with federal liability shield
H.R. 4019 — Gio’s Law · Filed by Laura Gillen (D-NY) · 9 cosponsors · Introduced Jun 17, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a federal grant program allowing the Attorney General to fund state and local law enforcement agencies to purchase epinephrine auto-injectors and train officers to recognize and treat anaphylactic shock. It requires the Attorney General to develop standardized training within 180 days, mandates that states certify legal liability protection for officers before receiving grants, authorizes $25 million annually through 2030, and directs the Justice Department to publish annual data on law enforcement epinephrine use and run a public awareness campaign.
Why we flagged it
The bill's operative mechanism is a straightforward federal grant program to equip and train law enforcement for emergency medical response. It is a public-health measure delivered through law enforcement infrastructure, not a commemorative or vanity bill despite bearing a person's name.
What the text implies
- Liability protection requirement (section 3063) may incentivize states to adopt broad immunity statutes for law enforcement, potentially extending beyond epinephrine administration to other police conduct.
- Annual reporting requirement creates a new federal data collection on law enforcement medical interventions, establishing precedent for federal oversight of police medical practices.
- Public awareness campaign (section 4) may shift public expectation that police, not paramedics, are primary responders to anaphylactic emergencies in some jurisdictions, affecting EMS resource allocation.
- Grant program structure creates federal funding dependency for local law enforcement, potentially influencing adoption of epinephrine protocols in under-resourced jurisdictions that might otherwise lack capacity.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill expands emergency medical capacity in law enforcement by equipping officers to treat life-threatening allergic reactions, potentially saving lives in communities where paramedics may be delayed. The liability protection requirement ensures officers are legally shielded when acting in good faith, removing a barrier to deployment of this life-saving intervention.
Who stands to gain
- epinephrine auto-injector manufacturers (e.g., Mylan/Viatris, Kaleo, Auvi-Q)
- medical device suppliers and distributors
- law enforcement training providers and consultants
Named in the bill
Attorney General, Bureau of Justice Statistics, Department of Health and Human Services, State attorneys general, State and local law enforcement agencies, Tribal law enforcement agencies, Mylan (Viatris), Kaleo, Auvi-Q
Where it stands
9 cosponsors: 6 Republicans, 3 Democrats.
- Jun 17, 2025 — Introduced · Congress.gov: “Introduced in House”
- Jun 17, 2025 — Referred to House Committee on the Judiciary · Congress.gov: “Referred to the House Committee on the Judiciary”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (3,032 characters) on Aug 18, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Police get epinephrine kits to treat allergic emergencies—with federal liability shield” QuorumCivic. https://share.quorumcivic.app/bill/119/hr4019 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.